Skip to main content

Technologies

35 results found
Pharmaceuticals / Nutraceuticals Software
Technologies
ID: 2021-010 Using the power of Junctional Adhesion Molecules combined with the target of CAR-T to inhibit cancer metastasis and eradicate tumors.
Technologies
ID: 2021-001 An advanced artificial intelligence algorithm that performs facial features and facial actions analysis concurrently for two-factor identity verification.
Technologies
ID: 2020-049 The intent of this program is to help students make informed decisions, and to help them curtail borrowing when possible to stay within manageable borrowing limits relative to anticipated future income.
Technologies
ID: 2020-021 This invention improves unmanned aerial vehicle (UAV) navigation by enabling small, fixed-wing aircraft to communicate with each other about their movements.
Technologies
ID: 2019-051 Researchers at BYU have discovered antioxidants that are significantly more effective than current available antioxidants.
Technologies
ID: 2019-015 Recombinant human Gal-1 treatment improves membrane repair capacity, increases myogenic markers and decreases inflammation in dysferlin deficient myotubes, providing novel evidence regarding how Gal-1 favorably improves muscle function in LGMD2B.
Technologies
ID: 2018-057 and 2014-098 BYU has discovered monocytes in the blood that provide a direct correlation to dopamine levels in the brain.
Technologies
ID: 2018-037 This technology is based on the use of phages infecting a bacteria and, as a byproduct of phage infection, antimicrobial components are released that can kill nearby infectious pathogens
Technologies
ID: 2018-035 The Paper Lateral Flow Immunoassay (pLFI) technique improves upon the traditional LFI, commonly recognized as diagnostic blood tests or pregnancy tests, reducing the costs of materials and precision in manufacturing.